About AutoIVF
AutoIVF is a company based in Natick (United States) founded in 2018 by Mitchel Sayare, Mehmet Toner, Thomas Toth, and Ravi Kapur. AutoIVF has raised $5 million across 3 funding rounds from investors including HHS, Vitrolife Group and Alpha Edison. AutoIVF offers products and services including Microfluidic IVF System. AutoIVF operates in a competitive market with competitors including Béa Fertility, Mosie Baby, Subhag, BendFlex and FertiliTech, among others.
- Headquarter Natick, United States
- Founders Mitchel Sayare, Mehmet Toner, Thomas Toth, Ravi Kapur
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Autoivf Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5 M (USD)
in 3 rounds
-
Latest Funding Round
$5 M (USD), Seed
May 08, 2025
-
Investors
HHS
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AutoIVF
AutoIVF offers a comprehensive portfolio of products and services, including Microfluidic IVF System.
Automates IVF procedures to boost reliability and cut costs effectively.
Funding Insights of AutoIVF
AutoIVF has successfully raised a total of $5M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $5 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AutoIVF
AutoIVF has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Vitrolife Group and Alpha Edison.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Series A and growth-stage investments are made by Alpha Edison.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Vitrolife Group is recognized as a global provider of medical devices and genetic testing solutions for reproductive health.
|
Locked | Locked | Locked |
Investor details for AutoIVF
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AutoIVF
Investment portfolio details for AutoIVF
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AutoIVF
Detailed financials for AutoIVF
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Autoivf Comparisons
Peer comparison for AutoIVF
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AutoIVF
AutoIVF operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Béa Fertility, Mosie Baby, Subhag, BendFlex and FertiliTech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of a device for fertility treatment
|
|
| Locked | Locked | Locked |
Home insemination solutions are offered for women's conception needs.
|
|
| Locked | Locked | Locked |
Infertility treatment devices are developed with patented technology.
|
|
| Locked | Locked | Locked |
A medical device is developed to enhance IVF success rates.
|
|
| Locked | Locked | Locked |
Embryo selection in IVF clinics is enhanced by time-lapse technology.
|
|
| Locked | Locked | Locked |
Provider of medical device for embryo and oocyte preservation
|
Detailed competitors of AutoIVF
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Autoivf
Complete news archive for AutoIVF
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AutoIVF
AutoIVF was founded in 2018 and raised its 1st funding round 4 years after it was founded.
AutoIVF is headquartered in Natick, United States. It is registered at Natick, Massachusetts, United States.
Ravi Kapur is the current CEO of AutoIVF. They have also founded this company.
AutoIVF is a funded company, having raised a total of $5M across 3 funding rounds to date.
AutoIVF was founded in 2018 and is based in Natick, United States. High-throughput microfluidic technologies are developed by the company to automate In Vitro Fertilization processes. Accessibility to IVF treatments is enhanced for infertility patients via these solutions. Operations focus on the biotechnology sector, with core activities centered on procedure optimization and automation to support clinical applications.
AutoIVF's top competitors include Béa Fertility, Subhag and FertiliTech.
AutoIVF offers Microfluidic IVF System.
AutoIVF has 3 investors. Key investors include HHS, Vitrolife Group, and Alpha Edison.